相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HuR's post-transcriptional regulation of death receptor 5 in pancreatic cancer cells
Danielle M. Pineda et al.
CANCER BIOLOGY & THERAPY (2012)
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
Ming Zhao et al.
CANCER SCIENCE (2012)
Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation
Takahisa Hirai et al.
CANCER SCIENCE (2012)
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
Feng Yang et al.
CANCER TREATMENT REVIEWS (2012)
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Anne Le et al.
CLINICAL CANCER RESEARCH (2012)
Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing
Christine A. Iacobuzio-Donahue et al.
CLINICAL CANCER RESEARCH (2012)
Heterogeneity and Targeting of Pancreatic Cancer Stem Cells
Vesselin R. Penchev et al.
CLINICAL CANCER RESEARCH (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2012)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
StellaTUM: current consensus and discussion on pancreatic stellate cell research
Mert Erkan et al.
GUT (2012)
Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition
Joost Kluiver et al.
PLOS ONE (2012)
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
Jordan M. Winter et al.
PLOS ONE (2012)
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
Kui Shen et al.
PLOS ONE (2012)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
L. D. Roy et al.
ONCOGENE (2011)
An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
Maeve A. Lowery et al.
ONCOLOGIST (2011)
Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
Brahma N. Singh et al.
PLOS ONE (2011)
High-Intensity Focused Ultrasound Ablation: Effective and Safe Therapy for Solid Tumors in Difficult Locations
Franco Orsi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer
Hong Zhao et al.
ANTI-CANCER DRUGS (2010)
Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
Evan S. Glazer et al.
CLINICAL CANCER RESEARCH (2010)
Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
Timothy D. Wiltshire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development
Itai Spector et al.
PANCREAS (2010)
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
Christina L. Costantino et al.
CANCER RESEARCH (2009)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Laetitia Devy et al.
CANCER RESEARCH (2009)
let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression
Jerme Torrisani et al.
HUMAN GENE THERAPY (2009)
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
Grant N. Scott et al.
JOURNAL OF IMMUNOLOGY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
Yu-Hung Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells
Shayna L. Showalter et al.
CANCER BIOLOGY & THERAPY (2008)
Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model
Xinting Pan et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Pancreatic stellate cells: Partners in crime with pancreatic cancer cells
Alain Vonlaufen et al.
CANCER RESEARCH (2008)
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent
Chitta Ranjan Patra et al.
CANCER RESEARCH (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
PAW-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma
David V. Gold et al.
CLINICAL CANCER RESEARCH (2007)
The fuzzy math of solid tumor stem cells: A perspective
Scott E. Kern et al.
CANCER RESEARCH (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Stromal biology of pancreatic cancer
Gerald C. Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Daruka Mahadevan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A proposed clinical test for monitoring fluoropyrimidine therapy - Detection and stability of thymidylate synthase ternary complexes
Jonathan R. Brody et al.
CANCER BIOLOGY & THERAPY (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
BRCA2 germline mutations in familial pancreatic carcinoma
SA Hahn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
SR Bramhall et al.
BRITISH JOURNAL OF CANCER (2002)
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial
SR Bramhall et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
